HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Willem van de Veen Selected Research

pembrolizumab

7/2019Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Willem van de Veen Research Topics

Disease

11Hypersensitivity (Allergy)
09/2021 - 04/2012
8Neoplasms (Cancer)
10/2023 - 06/2012
8Asthma (Bronchial Asthma)
01/2022 - 04/2012
6Food Hypersensitivity (Food Allergy)
03/2024 - 01/2018
6COVID-19
12/2022 - 01/2020
6Inflammation (Inflammations)
01/2022 - 06/2012
4Infections
01/2022 - 12/2020
3Autoimmune Diseases (Autoimmune Disease)
01/2021 - 06/2012
3Persistent Infection
10/2016 - 06/2012
2Melanoma (Melanoma, Malignant)
10/2023 - 01/2020
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 07/2019
2Anaphylaxis (Anaphylactic Shock)
12/2021 - 09/2021
2Atopic Dermatitis (Atopic Eczema)
12/2021 - 12/2019
2Obesity
01/2021 - 01/2018
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
01/2023
1Proctocolitis (Hemorrhagic Proctocolitis)
01/2023
1Eosinophilic enteropathy
01/2023
1Colitis
01/2023
1Eosinophilic Esophagitis
01/2023
1Enterocolitis
01/2023
1Venom Hypersensitivity
10/2022
1Virus Diseases (Viral Diseases)
01/2022
1Allergic Rhinitis
12/2021
1Chronic Urticaria
12/2021
1Rhinosinusitis
12/2021
1Drug Hypersensitivity (Drug Allergy)
12/2021
1Eosinophilia
09/2021
1Kidney Diseases (Kidney Disease)
01/2021
1Hypertension (High Blood Pressure)
01/2021
1Disease Progression
01/2021
1Lung Diseases (Lung Disease)
01/2021
1Agammaglobulinemia (Hypogammaglobulinemia)
12/2020
1Lymphopenia (Lymphocytopenia)
01/2020
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2020
1Cytokine Release Syndrome
01/2020
1Reinfection
12/2019
1Eczema
12/2019
1Job Syndrome (Hyper-IgE Syndrome)
12/2019
1Cancer Pain
01/2018

Drug/Important Bio-Agent (IBA)

9Immunoglobulin E (IgE)IBA
03/2024 - 04/2012
7CytokinesIBA
01/2022 - 06/2012
6AllergensIBA
01/2021 - 11/2014
4Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2018
4Biomarkers (Surrogate Marker)IBA
10/2022 - 04/2012
4Antiviral Agents (Antivirals)IBA
01/2022 - 01/2020
3VaccinesIBA
09/2021 - 01/2018
2Immunoglobulin G (IgG)IBA
12/2022 - 01/2020
2AntibodiesIBA
12/2022 - 01/2021
2InterferonsIBA
01/2022 - 09/2021
1Immune Checkpoint InhibitorsIBA
10/2023
1RNA (Ribonucleic Acid)IBA
01/2022
1AlarminsIBA
01/2022
1InflammasomesIBA
10/2021
1COVID-19 VaccinesIBA
09/2021
1InterleukinsIBA
01/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2021
1Interferon Type IIBA
01/2021
1C-Reactive ProteinIBA
01/2021
1ProcalcitoninIBA
01/2021
1Ferritins (Ferritin)IBA
01/2021
1Neutralizing AntibodiesIBA
12/2020
1Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2020
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
12/2019
1Blocking AntibodiesIBA
12/2019
1AntigensIBA
07/2019
1pembrolizumabIBA
07/2019
1NivolumabIBA
07/2019
1AllergoidsIBA
01/2018
1EndocannabinoidsIBA
01/2018
1CannabinoidsIBA
01/2018
1Peptides (Polypeptides)IBA
01/2018
1AutoantigensIBA
12/2017
1ChemokinesIBA
09/2013
1Interleukin-17 (Interleukin 17)IBA
06/2012
1Interleukin-22 (IL-22)IBA
06/2012

Therapy/Procedure

3Organ Transplantation
01/2023 - 06/2012
3Transplantation
01/2021 - 04/2013
3Immunotherapy
01/2020 - 11/2014
2Therapeutics
01/2020 - 07/2019
1Precision Medicine
12/2020